These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 73567)

  • 21. [Importance of determining steroid hormone receptors and the treatment of prostatic cancer].
    Fedotov IA; Denisov LE; Kozlov VP; Degtiar' VG
    Urol Nefrol (Mosk); 1983; (1):63-70. PubMed ID: 6187115
    [No Abstract]   [Full Text] [Related]  

  • 22. Histochemical observation of F 1881 binding protein in human benign prostatic hypertrophy.
    Naito H; Ito H; Wakisaka M; Kambegawa A; Shimazaki J
    Invest Urol; 1981 Mar; 18(5):337-40. PubMed ID: 6162820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen glucuronide. II. DIfferences in its formation by human normal and benign hyperplastic prostates.
    Chung LW; Coffey DS
    Invest Urol; 1978 Mar; 15(5):385-8. PubMed ID: 76619
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytopathological changes in early stages of benign prostatic hyperplasia upon exposure to sustained delivery of androgens.
    Pollan MC; Benghuzzi HA; Tucci M
    Biomed Sci Instrum; 2002; 38():15-20. PubMed ID: 12085593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some aspects of the pathogenesis of prostatic hyperplasia.
    Tveter KJ
    Acta Pathol Microbiol Scand Suppl; 1974; Suppl 248():167-74. PubMed ID: 4141576
    [No Abstract]   [Full Text] [Related]  

  • 26. Testosterone metabolism in prostate; formation of androstan-17-beta-ol-3-one and androst-4-ene-3, 17-dione, and inhibitory effect of natural and synthetic estrogens.
    Shimazaki J; Kurihara H; Ito Y; Shida K
    Gunma J Med Sci; 1965 Dec; 14(4):313-25. PubMed ID: 4162344
    [No Abstract]   [Full Text] [Related]  

  • 27. Sex steroid production and secretion in the male.
    Horton R
    Andrologia; 1978; 10(3):183-94. PubMed ID: 80142
    [No Abstract]   [Full Text] [Related]  

  • 28. [Androgen receptors in target tissues and tumors].
    Sharoukhova KS
    Vopr Onkol; 1979; 25(5):75-80. PubMed ID: 88807
    [No Abstract]   [Full Text] [Related]  

  • 29. Growth factor expression in early stages of benign prostatic hyperplasia upon exposure to sustained delivery of androgens.
    Pollan MC; Benghuzzi HA; Tucci M
    Biomed Sci Instrum; 2003; 39():329-34. PubMed ID: 12724915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proceedings: Androgen dynamics in vitro in the prostate gland.
    Giorgi EP; Moses T; Grant JK
    J Endocrinol; 1974 Apr; 61(1):17-8. PubMed ID: 4857262
    [No Abstract]   [Full Text] [Related]  

  • 31. Testosterone metabolism in benign prostatic hypertrophy. Suppression by diethylstilbestrol and gestonorone capronate.
    Orestano F; Klose K; Rubin A; Knapstein P; Altwein JE
    Invest Urol; 1974 Sep; 12(2):151-6. PubMed ID: 4137236
    [No Abstract]   [Full Text] [Related]  

  • 32. Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system.
    Kurita T; Wang YZ; Donjacour AA; Zhao C; Lydon JP; O'Malley BW; Isaacs JT; Dahiya R; Cunha GR
    Cell Death Differ; 2001 Feb; 8(2):192-200. PubMed ID: 11313721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proceedings: Studies on the mechanism of entry of androgens into canine prostate.
    Giorgi EP
    J Endocrinol; 1975 Jun; 65(3):33P. PubMed ID: 1151230
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and experimental studies of benign prostatic hyperplasia.
    Coffey DS; Walsh PC
    Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J; Hicks LL; Walsh PC
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of prostate growth.
    Coffey DS; Isaacs JT
    Urology; 1981 Mar; 17(Suppl 3):17-24. PubMed ID: 6163242
    [No Abstract]   [Full Text] [Related]  

  • 37. The metabolism of [4-14C] progesterone by hypertrophic and carcinomatous human prostate tissue.
    Acevedo HF; Goldzieher JW
    Biochim Biophys Acta; 1965 Nov; 111(1):294-8. PubMed ID: 4160135
    [No Abstract]   [Full Text] [Related]  

  • 38. Benign prostatic hyperplasia: the best treatment.
    Chisholm GD
    BMJ; 1989 Jul; 299(6693):215-6. PubMed ID: 2475197
    [No Abstract]   [Full Text] [Related]  

  • 39. [Progesterone, androgens, aldosteron: study of their metabolism: importance of their biological determination in clinical medicine].
    Cession G
    Rev Med Liege; 1969 Mar; 24(5):211-6. PubMed ID: 5407236
    [No Abstract]   [Full Text] [Related]  

  • 40. Conjugated androstenedione in urine [proceedings].
    Goodall A; James VH
    J Endocrinol; 1977 Dec; 75(3):27P-28P. PubMed ID: 73567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.